Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 19:58
Lexicon Pharmaceuticals Market Cap : 1.034B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.023B |
| August 20, 2026 | 969.96M |
| August 19, 2026 | 1.072B |
| August 18, 2026 | 1.077B |
| August 17, 2026 | 1.041B |
| August 14, 2026 | 1.032B |
| August 13, 2026 | 1.041B |
| August 12, 2026 | 1.046B |
| August 11, 2026 | 1.081B |
| August 10, 2026 | 1.068B |
| August 07, 2026 | 1.099B |
| August 06, 2026 | 1.050B |
| August 05, 2026 | 1.090B |
| August 04, 2026 | 1.108B |
| August 03, 2026 | 987.40M |
| July 31, 2026 | 978.92M |
| July 30, 2026 | 991.63M |
| July 29, 2026 | 983.16M |
| July 28, 2026 | 991.63M |
| July 27, 2026 | 945.02M |
| July 24, 2026 | 970.44M |
| July 23, 2026 | 974.68M |
| July 22, 2026 | 953.49M |
| July 21, 2026 | 1.009B |
| July 20, 2026 | 987.40M |
| Date | Value |
|---|---|
| July 17, 2026 | 1.013B |
| July 16, 2026 | 949.26M |
| July 15, 2026 | 932.30M |
| July 14, 2026 | 898.40M |
| July 13, 2026 | 919.59M |
| July 10, 2026 | 940.78M |
| July 09, 2026 | 953.49M |
| July 08, 2026 | 961.97M |
| July 07, 2026 | 1.004B |
| July 06, 2026 | 983.16M |
| July 02, 2026 | 983.16M |
| July 01, 2026 | 991.63M |
| June 30, 2026 | 1.017B |
| June 29, 2026 | 1.119B |
| June 26, 2026 | 1.081B |
| June 25, 2026 | 970.44M |
| June 24, 2026 | 940.78M |
| June 23, 2026 | 915.35M |
| June 22, 2026 | 911.12M |
| June 18, 2026 | 851.79M |
| June 17, 2026 | 864.50M |
| June 16, 2026 | 826.36M |
| June 15, 2026 | 830.60M |
| June 12, 2026 | 813.65M |
| June 11, 2026 | 800.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 19.11B |
| Pfizer Inc. | 159.46B |
| ANI Pharmaceuticals, Inc. | 1.705B |
| Corcept Therapeutics, Inc. | 13.30B |
| Veru, Inc. | 44.50M |
Market Cap Related Metrics
| PS Ratio | 21.93 |
| Price to Book Value | 5.927 |
| Price | 2.325 |
| Earnings Yield | -6.58% |